{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:13:29Z","timestamp":1697051609169},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T00:00:00Z","timestamp":1091664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The association of cutaneous lymphoproliferative diseases and primary hyperparathyroidism (PHP) is infrequent, with only three cases reported to date. We present a patient with lymphomatoid papulosis (LyP) who developed hypercalcaemia secondary to parathyroid nodular hyperplasia. A review of the literature has revealed no similar cases; we therefore believe this to be the first description of the association between LyP and PHP.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2004.01033.x","type":"journal-article","created":{"date-parts":[[2004,10,11]],"date-time":"2004-10-11T15:40:55Z","timestamp":1097509255000},"page":"693-696","source":"Crossref","is-referenced-by-count":4,"title":["Lymphomatoid papulosis associated with parathyroid nodular hyperplasia: report of a case"],"prefix":"10.1111","volume":"18","author":[{"given":"M","family":"Aguilar\u2010Bernier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bassas\u2010Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MT","family":"Bordel\u2010Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Morales\u2010Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JA","family":"Tejerina\u2010Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Miranda\u2010Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,5]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930370104"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.26.2.66"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051733"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03252.x"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196603242741208"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197411142912001"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197512182932502"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.68.803.753"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.634"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64694-9"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.1999.0880"},{"key":"e_1_2_4_14_2","doi-asserted-by":"crossref","unstructured":"LeviE WangZ Petrogiannis\u2010HaliotisTet al.Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanisms for disease progression.J Invest Dermatol2000;115:1034\u20131040.","DOI":"10.1046\/j.1523-1747.2000.00175.x"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1996.tb04944.x"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04966.x"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01794.x"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04523.x"},{"key":"e_1_2_4_19_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archderm.1997.03890430031005","article-title":"Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases","volume":"133","author":"Kikuchi A","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480081"},{"key":"e_1_2_4_21_2","unstructured":"WillemzeR KerlH SterryWet al.EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.Blood1997;90:354\u2013371."}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2004.01033.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2004.01033.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:43:50Z","timestamp":1697049830000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2004.01033.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,5]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1468-3083.2004.01033.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2004.01033.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,5]]}}}